Cell Signaling Technology

Product Pathways - Cell Cycle / Checkpoint

Bub3 Antibody #3049


No. Size Price
3049S 100 µl ( 10 western blots ) ¥3,250.00 现货查询 购买询价 防伪查询
3049 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse,Rat,Hamster,Monkey, Endogenous 40 Rabbit

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting,

Specificity / Sensitivity

Bub3 Antibody detects endogenous levels of total Bub3 protein. Bub3抗体能够检测内源性的Bub3总蛋白。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to carboxy-terminal residues of human Bub3. 该多克隆抗体是由合成的人源的针对Bub3蛋白羧基末端肽段免疫动物而生产的。

Western Blotting

Western Blotting

Western blot analysis of extracts from various cell types using Bub3 Antibody. 使用Bub3 抗体利用western blot 技术检测一系列细胞提取物。


The Mitotic Checkpoint Complex (MCC), which contains Bub1, Bub1b, Bub3, Mad2, and Cdc20, controls chromosome segregation and monitors kinetochore-microtubule interactions (1). During mitosis, the MCC complex inhibits the ubiquitin ligase activity of the Anaphase Promoting Complex/Cyclosome (APC/C), thereby preventing cells with unaligned chromosomes from prematurely entering anaphase (2). Bub1b and Bub1 kinases are mutated in several types of human malignancies including hematopoietic, colorectal, lung, and breast cancers (3). Biallelic mutations in Bub1b have been found in mosaic variegated aneuploidy syndrome and premature chromatid separation syndrome (4). Bub1b mouse germline knockouts are embryonic lethal with heterozygous animals displaying genetic instability, early aging phenotypes, and increased cancer susceptibility (5). Bub3 binds both Bub1 and Bub1b, facilitating their recruitment to kinetochores (6), and is required for functional microtubule-kinetochore interactions (7). 有丝分类检验点复合体(MCC)包括Bub1,Bub1b,Bub3,Mad2和Cdc20,它们控制染色体分离并监视着丝粒-微管相互作用(1)。有丝分裂中,MCC抑制泛素连接酶APC/C的活性,从而防止染色体未配对的细胞过早地进入分裂后期(2)。在多种人类恶性肿瘤如造血癌、结肠癌、肺癌和乳腺癌中存在Bub1b 和Bub1激酶的突变(3)。在花叶杂色非整倍体综合征和过早染色单体分离综合征中都发现了Bub1b等位基因的突变(4)。小鼠生殖细胞Bub1b敲除后胚胎致死,动物杂合子显示出基因组不稳定性,早老表型,癌症易感性增加(5)。Bub3能够结合Bub1和Bub1b,促进其在着丝粒的招募(6),并参与功能性的微管-着丝粒相互作用(7)。

  1. Fukagawa, T. (2008) Front Biosci 13, 2705-13.
  2. Chen, R.H. (2007) J Biomed Sci 14, 475-9.
  3. Dai, W. et al. (2004) Cancer Res 64, 440-5.
  4. Kops, G.J. et al. (2005) Nat Rev Cancer 5, 773-85.
  5. Baker, D.J. et al. (2004) Nat Genet 36, 744-9.
  6. Taylor, S.S. et al. (1998) J Cell Biol 142, 1-11.
  7. Logarinho, E. et al. (2008) Mol Biol Cell 19, 1798-813.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :